Inventor · disambiguated record
Steven D. E. Sullivan
Also filed as: SULLIVAN STEVEN D E
17 granted patents·2 pending applications·151 citations·filing 2016–2023
94Inventor score
Top patents by PatentIndex Score
19 records- 0198US10526330B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jan 7, 2020·15 cites·13 claims
- 0298US10208040B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 19, 2019·24 cites·31 claims
- 0398US10196393B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Feb 5, 2019·24 cites·12 claims
- 0498US10100049B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Oct 16, 2018·28 cites·17 claims
- 0597US10550118B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 4, 2020·13 cites·10 claims
- 0697US10519153B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Dec 31, 2019·16 cites·22 claims
- 0797US10392386B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 27, 2019·19 cites·10 claims
- 0894US11453668B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Sep 27, 2022·2 cites·20 claims
- 0993US11299492B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Apr 12, 2022·2 cites·13 claims
- 1093US11254669B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 22, 2022·3 cites·17 claims
- 1192US10954237B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 23, 2021·2 cites·18 claims
- 1284US11878977B2JAK inhibitors containing a 4-membered heterocyclic amideTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Jan 23, 2024·0 cites·5 claims
- 1384US11590116B2Substituted pyridines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Feb 28, 2023·1 cites·25 claims
- 1483US10952996B2ALK5 inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 23, 2021·2 cites·20 claims
- 1581US11667637B2Fused imidazo-piperidine JAK inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Jun 6, 2023·0 cites·19 claims
- 1679US11718616B2JAK kinase inhibitor compounds for treatment of respiratory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Aug 8, 2023·0 cites·7 claims
- 1770US2023218597A1Substituted pyridines and methods of useTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Application pending·0 cites
- 1862US11730720B2ALK5 inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Aug 22, 2023·0 cites·28 claims
- 1961US2025313535A1Alpha 4 beta 7 integrin modulators and uses thereofDICE MOLECULES SV INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven D. E. Sullivan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →